AKC Canine Health Foundation

e-Update

June 2023

Groundbreaking Study to Evaluate Potential Treatment for Degenerative Myelopathy

With CHF funding, investigators at four veterinary teaching hospitals are collaborating to set-up clinical trials and establish treatment protocols for dogs with degenerative myelopathy using riluzole, the first drug approved by the FDA to treat ALS or Lou Gehrig’s Disease in humans in 1995.

Read the press release

2023 National Parent Club Canine Health Conference

Register now to get the latest outcomes from CHF-funded canine health research directly from the researchers at our August conference. Both in-person and virtual attendance options are available.

New Ways to Find and Treat Canine Cancer

Dr. Charles Garvin, Chairman of the CHF Board of Directors, discusses grants funded for studies of innovative new ways to detect and treat cancer on the Tracie Hotchner Pets podcast.

Listen to the podcast

2023 Small Animal Theriogenology Resident

CHF announces the 2023 American Kennel Club/AKC Canine Health Foundation/Theriogenology Foundation Small Animal Theriogenology Residency Recipient.

Read the press release

CHF On the Road

CHF staff are on the road – making connections with dog lovers, researchers, and everyone involved in canine health. This month, CHF attended the American College of Veterinary Internal Medicine Forum in Philadelphia, PA to interact with our funded investigators and veterinary professionals interested in cutting edge veterinary medicine.

See where we'll be next

Established in 1995, the AKC Canine Health Foundation's (CHF) mission is to advance the health of all dogs and their owners by funding scientific research and supporting the dissemination of health information to prevent, treat and cure canine disease.

CONNECT WITH US: